NDC 0143-9566

Azathioprine Sodium

Azathioprine Sodium

Azathioprine Sodium is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp. The primary component is Azathioprine Sodium.

• Product ID: 0143-9566_3abe1b5b-f979-499b-b524-f662a226ac53
• NDC: 0143-9566
• Product Type: Human Prescription Drug
• Proprietary Name: Azathioprine Sodium
• Generic Name: Azathioprine Sodium
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1995-05-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA074419
• Labeler Name: West-Ward Pharmaceuticals Corp
• Substance Name: AZATHIOPRINE SODIUM
• Active Ingredient Strength: 100 mg/10mL
• Pharm Classes: Nucleic Acid Synthesis Inhibitors [MoA],Nucleosides [CS],Purine Antimetabolite [EPC],Purines [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0143-9566-01

1 VIAL in 1 BOX, UNIT-DOSE (0143-9566-01) > 10 mL in 1 VIAL

• Marketing Start Date: 1995-05-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0143-9566-01 [00143956601]

Azathioprine Sodium INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA074419
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1995-05-01

Drug Details

Active Ingredients

Ingredient	Strength
AZATHIOPRINE SODIUM	100 mg/10mL

OpenFDA Data

• SPL SET ID: 9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0
• Manufacturer:
  • West-Ward Pharmaceuticals Corp
• UNII:
  • AM94R510MS
• RxNorm Concept Unique ID - RxCUI:
  • 239983

Pharmacological Class

• Nucleoside Analog [EXT]
• Purine Antimetabolite [EPC]
• Purines [CS]
• Nucleic Acid Synthesis Inhibitors [MoA]
• Nucleic Acid Synthesis Inhibitors [MoA]
• Nucleosides [CS]
• Purine Antimetabolite [EPC]
• Purines [CS]